5.6TWD
251.01 MTWD
1.11 BTWD
31.84 M
About SYN-TECH CHEM. & PHARM. CO
Sector
CEO
Yi Feng Wang
Headquarters
Tainan
Website
Founded
1982
ISIN
TW0001777001
FIGI
BBG000M116L4
SYN-TECH Chemical & Pharmaceutical Co., Ltd. engages in the research, development, and manufacture of active pharmaceutical ingredients. Its products include local anesthetics, cardiovascular drugs, muscle relaxants, respiratory drugs, central nervous system drugs, digestive system drugs, urinary system drugs, and topical drugs. The company was founded on November 9, 1982 and is headquartered in Tainan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1777 is 82.2 TWD — it has increased by 0.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange SYN-TECH CHEM. & PHARM. CO stocks are traded under the ticker 1777.
SYN-TECH CHEM. & PHARM. CO is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
1777 stock is 0.61% volatile and has beta coefficient of 0.07. Check out the list of the most volatile stocks — is SYN-TECH CHEM. & PHARM. CO there?
1777 earnings for the last quarter are 1.47 TWD per share, whereas the estimation was 1.17 TWD resulting in a 25.64% surprise. The estimated earnings for the next quarter are 1.28 TWD per share. See more details about SYN-TECH CHEM. & PHARM. CO earnings.
SYN-TECH CHEM. & PHARM. CO revenue for the last quarter amounts to 267.00 M TWD despite the estimated figure of 220.00 M TWD. In the next quarter revenue is expected to reach 255.00 M TWD.
Yes, you can track SYN-TECH CHEM. & PHARM. CO financials in yearly and quarterly reports right on TradingView.
1777 stock has fallen by 0.24% compared to the previous week, the month change is a 1.91% fall, over the last year SYN-TECH CHEM. & PHARM. CO has showed a 3.86% decrease.
1777 net income for the last quarter is 25.47 M TWD, while the quarter before that showed 92.48 M TWD of net income which accounts for −72.45% change. Track more SYN-TECH CHEM. & PHARM. CO financial stats to get the full picture.
Today SYN-TECH CHEM. & PHARM. CO has the market capitalization of 3.67 B, it has increased by 0.24% over the last week.
Yes, 1777 dividends are paid annually. The last dividend per share was 3.00 TWD. As of today, Dividend Yield (TTM)% is 3.65%. Tracking SYN-TECH CHEM. & PHARM. CO dividends might help you take more informed decisions.
SYN-TECH CHEM. & PHARM. CO dividend yield was 4.11% in 2023, and payout ratio reached 62.18%. The year before the numbers were 3.56% and 45.30% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1777 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYN-TECH CHEM. & PHARM. CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYN-TECH CHEM. & PHARM. CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYN-TECH CHEM. & PHARM. CO stock shows the neutral signal. See more of SYN-TECH CHEM. & PHARM. CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYN-TECH CHEM. & PHARM. CO EBITDA is 393.61 M TWD, and current EBITDA margin is 35.31%. See more stats in SYN-TECH CHEM. & PHARM. CO financial statements.